药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pivampicillin
Satralizumab
The serum concentration of Prednisolone phosphate can be decreased when it is combined with Satralizumab.
Pivampicillin
Abametapir
The serum concentration of Prednisolone phosphate can be increased when it is combined with Abametapir.
Pivampicillin
Mebutizide
The risk or severity of electrolyte imbalance can be increased when Prednisolone phosphate is combined with Mebutizide.
Pivampicillin
Cyclopenthiazide
The risk or severity of electrolyte imbalance can be increased when Prednisolone phosphate is combined with Cyclopenthiazide.
Pivampicillin
Cenobamate
The serum concentration of Cenobamate can be decreased when it is combined with Prednisolone phosphate.
Pivampicillin
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Yersinia pestis 195/p antigen (formaldehyde inactivated)
The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Pertussis vaccine
The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Smallpox (Vaccinia) Vaccine, Live
The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Human adenovirus e serotype 4 strain cl-68578 antigen
The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone phosphate.